Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Novartis recalls three lots of Promacta due to potential peanut contamination

      Novartis recalls three lots of Promacta due to potential peanut contamination

      Farhat Nasim14 May 2019 10:00 AM IST
      New Delhi: Novartis recently announced a voluntary recall of three lots of Promacta (eltrombopag) 12.5 mg for oral suspension to the consumer level....
      JnJ baby shampoo on attack; gets BANNED in Uttar Pradesh

      JnJ baby shampoo on attack; gets BANNED in Uttar Pradesh

      Farhat Nasim13 May 2019 10:35 AM IST
      New Delhi: Notable pharmaceutical firm Johnson and Johnson (JnJ) is in a soup as its popular baby shampoo has been banned in Uttar Pradesh. According...
      Zydus Cadila gets USFDA nod for Chlorthalidone tablets to treat high BP

      Zydus Cadila gets USFDA nod for Chlorthalidone tablets to treat high BP

      Farhat Nasim13 May 2019 10:31 AM IST
      Zydus Cadila said Chlorthalidone tablets will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.New Delhi: Drug...
      Torrent Pharma recalls over 8.82 lakh bottles of Losartan Potassium tablets from US, Puerto Rico

      Torrent Pharma recalls over 8.82 lakh bottles of Losartan Potassium tablets from US, Puerto Rico

      Farhat Nasim13 May 2019 10:00 AM IST
      The company is recalling 3,31,764 bottles of Losartan Potassium and Hydrochlorothiazide tablets, USP, 50mg/12.5mg from the US and Puerto Rico, the...
      Certain Medtronic pacemaker batteries fail without warning; USFDA flags issue

      Certain Medtronic pacemaker batteries fail without warning; USFDA flags issue

      Farhat Nasim13 May 2019 9:33 AM IST
      New Delhi: US Food and Drug Administration (FDA) has recently issued safety alarm about premature battery depletion without warning patients or health...
      AstraZeneca shows cardiovascular safety for roxadustat in global Phase III trials

      AstraZeneca shows cardiovascular safety for roxadustat in global Phase III trials

      Farhat Nasim12 May 2019 10:15 AM IST
      New Delhi: AstraZeneca recently announced top-line results from the pooled cardiovascular (CV) safety analyses of the global Phase III programme for...
      Eli Lilly new migraine drug Emgality pulls ahead of Amgen in battle for prescriptions

      Eli Lilly new migraine drug Emgality pulls ahead of Amgen in battle for prescriptions

      Farhat Nasim12 May 2019 9:30 AM IST
      Weekly U.S. prescription data from IQVIA, an analytics provider to the life sciences industry, showed that Lilly's therapy Emgality claimed the...
      Fortis tightens financial noose around Singh brothers; likely to move Delhi HC

      Fortis tightens financial noose around Singh brothers; likely to move Delhi HC

      Farhat Nasim11 May 2019 5:43 PM IST
      New Delhi: Surrounded by controversies, Singh brothers is likely to face judicature as Fortis Healthcare Ltd (FHL) plans to a reach out to the Delhi...
      Indoco Remedies

      Indoco Remedies' new solid dosages facility at Baddi gets UK-MHRA nod

      Farhat Nasim11 May 2019 10:00 AM IST
      Indoco Remedies' new Baddi facility is spread over an area of 18000 sqm, with a manufacturing capacity of 4.3 billion tablets and 50 million capsules...
      Pfizer gets USFDA approval for Vyndaqel, Vyndamax to treat amyloidosis cardiomyopathy

      Pfizer gets USFDA approval for Vyndaqel, Vyndamax to treat amyloidosis cardiomyopathy

      Farhat Nasim11 May 2019 9:15 AM IST
      New Delhi: Pfizer Inc's subsidiary FoldRx, has recently won U.S. Food and Drug Administration (USFDA) approved for Vyndaqel (tafamidis meglumine) and...
      Lupin launches generic Clobazam tablets to treat seizures

      Lupin launches generic Clobazam tablets to treat seizures

      Farhat Nasim10 May 2019 10:45 AM IST
      The company has launched Clobazam tablets in the strengths of 10 mg and 20 mg, after having received an approval from the United States Food and Drug...
      Not passing GST benefit to consumers: Abbott gets HC relief after Challenging powers of National Anti-Profiteering Authority

      Not passing GST benefit to consumers: Abbott gets HC relief after Challenging powers of National Anti-Profiteering Authority

      Farhat Nasim9 May 2019 2:11 PM IST
      New Delhi: In an interim relief, the Delhi High Court has stayed proceedings against Abbott Healthcare which was found guilty by the National...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok